Ticker

No recent analyst price targets found for CTTH.

Latest News for CTTH

CTT Pharma Receives SEC Approval

August 5, 2026 – TheNewswire - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) is pleased to announce the company has been formally approved by the SEC for our S-1 and will now be a SEC reporting company. This is an important milestone as CTT Pharma is now an audited, SEC reporting company on the OTCQB and will start filing an SEC form 8-K when material events occur. CTT will update shareholders as more news becomes…

TheNewswire • Aug 5, 2026
CTT Pharma Signs LOI with European Company

May 14, 2026 – TheNewswire - CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has signed an LOI with a company in Europe for a potential strategic partnership. A partnership with this group would allow CTT additional opportunities to monetize the company's patented technology in Europe and the United States. CTT Pharma will notify shareholders as more information becomes available. About CTT Pharmaceutical Holdings,…

TheNewswire • May 14, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for CTTH.

No House trades found for CTTH.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top